
Warning: Attempt to read property "ID" on null in /usr/home/sniznik/domains/celon.group/public_html/wp-content/themes/celon/assets/functions/cleanup.php on line 74

Warning: Attempt to read property "ID" on null in /usr/home/sniznik/domains/celon.group/public_html/wp-content/themes/celon/assets/functions/cleanup.php on line 74
<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>CelonGROUP</provider_name><provider_url>https://celon.group/en/</provider_url><author_name>Ma&#x142;gorzata Siewierska</author_name><author_url>https://celon.group/en/author/malgorzata-siewierska/</author_url><title>Announcement of the Management Board of Celon Pharma S.A. - CelonGROUP</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="WYevn6D27j"&gt;&lt;a href="https://celon.group/en/2017/10/09/14091/"&gt;Announcement of the Management Board of Celon Pharma S.A.&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://celon.group/en/2017/10/09/14091/embed/#?secret=WYevn6D27j" width="600" height="338" title="&#x201C;Announcement of the Management Board of Celon Pharma S.A.&#x201D; &#x2014; CelonGROUP" data-secret="WYevn6D27j" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script&gt;
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://celon.group/wp-includes/js/wp-embed.min.js
&lt;/script&gt;
</html><description>Ladies and Gentlemen, In connection with the information provided yesterday by Selvita S.A. on withholding the clinical programme for SEL24, the Management Board of Celon Pharma S.A. informs that such situations occur naturally in the process of creating innovative medicinal products, as demonstrated by numerous examples of clinical projects carried out in American or EuropeanRead more &raquo;</description></oembed>
